Literature DB >> 3819908

Evaluation of double-exposure holographic interferometry for biomechanical measurements in vitro.

M T Manley, B Ovryn, L S Stern.   

Abstract

Double-exposure holographic interferometry is a nondestructive testing technique for measuring displacement and strain in a test object. A standard hologram contains three-dimensional information about an object. However, the holographic interferogram has additional information, as a series of interference bands overlaid on the three-dimensional image of the object contains information about object deformation. Interferograms were produced for intact cadaveric femora and cadaveric femora with implanted titanium alloy and cobalt-chromium alloy femoral components. A force was applied to the femoral head to simulate single leg stance, and changes in specimen deformation were observed as additional incremental loads were applied. We have observed that the femur behaves as a bending beam and that the holographic technique allows the position of maximal deflection to be identified and the magnitude of femoral displacement from the load axis to be determined at any point within the field of view. The effects of the modulus of the implanted stem on the bending characteristics of the composite structure were clearly seen in the interferograms. This communication presents a photographic analysis of the double exposure interferograms recorded, as well as a critique of the technique for biomechanical measurements in vitro.

Entities:  

Mesh:

Year:  1987        PMID: 3819908     DOI: 10.1002/jor.1100050119

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  2 in total

1.  Holographic interferometry: a critique of the technique and its potential for biomedical measurements.

Authors:  B Ovryn; M T Manley; L S Stern
Journal:  Ann Biomed Eng       Date:  1987       Impact factor: 3.934

2.  Biomechanical investigation of the hyoid bone using speckle interferometry.

Authors:  H Kasprzak; H Podbielska; G von Bally; G Fechner
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.